Mutual Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Mutual Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	BUY	$0.46 - $0.81 $2,300 - $4,050	5,000 Added 22.63%	27,095 $17,000
Q3 2022 Nov 03, 2022	SELL	$1.04 - $322.5 $15,600 - $4.84 Million	-15,000 Reduced 40.44%	22,095 $38,000
Q1 2022 May 09, 2022	BUY	$0.62 - $1.17 $1,240 - $2,340	2,000 Added 5.7%	37,095 $24,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $19,287 - $33,443	17,695 Added 101.7%	35,095 $38,000
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $25,056 - $47,502	17,400 New	17,400 $32,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Advisors, LLC with notifications on news.